Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm

Joanna Mitchell1, Robert Arnold, Kate Dawson

  • 1Department of Clinical Neuroscience, Addenbrooke's Hospital, Cambridge, UK.

Insights

Mild cognitive impairment (MCI) progression to dementia varies. Multi-domain MCI has a high conversion rate, while pure amnestic MCI is more benign, with specific cognitive tests predicting prognosis.

Area of Science:

  • Neurology
  • Gerontology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) is a known risk factor for dementia.
  • Current diagnostic criteria lead to varied estimates of MCI conversion rates.
  • Simple cognitive predictors for high and low risk of MCI progression are lacking.

Purpose of the Study:

  • To investigate the differing progression rates of various MCI subtypes.
  • To identify simple cognitive predictors for MCI progression.
  • To differentiate outcomes for pure amnestic MCI versus multi-domain MCI.

Main Methods:

  • Followed 107 non-demented, non-depressed subjects classified into pure amnestic MCI, multi-domain MCI, non-amnestic MCI, and worried well groups.
  • Assessed outcomes at 2 years, including progression to dementia and improvement.
  • Utilized the Addenbrooke's Cognitive Examination (ACE) and Paired Associate Learning (PAL) task to identify predictors.

Main Results:

  • Multi-domain MCI showed a 59% progression to dementia and 5% improvement.
  • Pure amnestic MCI had an 18% progression rate and 41% improvement.
  • Non-amnestic MCI patients demonstrated a 70% improvement rate.
  • A combination of ACE and PAL scores provided high negative predictive (90%) and sensitivity (94%) values for progression.

Conclusions:

  • Outcomes differ significantly between pure amnestic MCI (benign, unstable) and multi-domain MCI (aggressive).
  • High ACE scores (>88) or low PAL errors (<14) indicate a good prognosis.
  • These findings aid in differentiating MCI subtypes and predicting dementia risk.